BD CD3 (SK7) FITC; IVD; Catalog # 349201 and 340542 Hematology: The CD3 antibody reacts with ...
FDA Device Recall #Z-0171-2016 — Class III — September 30, 2015
Recall Summary
| Recall Number | Z-0171-2016 |
| Classification | Class III — Low risk |
| Date Initiated | September 30, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Becton, Dickinson and Company, BD Biosciences |
| Location | San Jose, CA |
| Product Type | Devices |
| Quantity | 120 units |
Product Description
BD CD3 (SK7) FITC; IVD; Catalog # 349201 and 340542 Hematology: The CD3 antibody reacts with the epsilon chain of the CD3 antigen/T-cell antigen receptor (TCR) complex. In vitro diagnostic.
Reason for Recall
Two lots of CD3 (SK7) FITC label contains an error in the Spanish Small text.
Distribution Pattern
US (nationwide) Distribution to the states of : TX, GA, IN, TN, CA, KY, WA, IL, MO, NY, CT, MN, NV, KS, WI, NH, FL, PA, OH, OR, SC. OK, NC and LA., and Internationally to Mexico.
Lot / Code Information
Catalog Number: 349201; Lot Number 5148598 (expires 10-31-2016) Catalog Number: 340542; Lot Number 5113983 (expires 02-28-2017)
Other Recalls from Becton, Dickinson and Company, BD Bio...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2351-2024 | Class II | BD Multitest 6-Color TBNK CE-IVD, REF: 644611; ... | May 8, 2024 |
| Z-0641-2024 | Class II | CD11b APC: ASR, REF: 340936, and CE, REF: 333143 | Oct 25, 2023 |
| Z-0173-2023 | Class II | BD Multitest 6-Color TBNK with optional BD Truc... | Oct 3, 2022 |
| Z-0172-2023 | Class II | BD Trucount Tubes (Cat. No. 663028), used for d... | Oct 3, 2022 |
| Z-0171-2023 | Class II | BD Trucount Tubes (Cat. No. 340334), used for d... | Oct 3, 2022 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.